Maniez-Montreuil M, Dupressoir-Burlet M V, Goudemand M
Rev Fr Transfus Immunohematol. 1982 Jun;25(3):245-63. doi: 10.1016/s0338-4535(82)80011-1.
A procedure for determining anti-HBc of IgM class is described herein. After IgG anti-HBc antibodies have been preferentially absorbed with Staphylococcus aureus cells positive for protein A, we have tested for residual IgM anti-HBc in the supernatant (absorbed serum) by radioimmunoassay. The occurrence and time course of anti-HBc, studied in 3 patients with ongoing infection, show that IgM anti-HBc persist for about 2 months in cases of acute hepatitis. IgM anti-HBc --marker for a recent HBV infection-- was found to be a useful tool in diagnosis of an unapparent hepatitis with transient or undetectable HBs antigenemia (case no 5). The presence of IgM or IgG anti-HBc, HBeAg and anti-HBe was determined by radioimmunoassay in 68 patients HBsAg positive. The immunoglobulin classes (IgM or IgG) of anti-HBc are dependent on the phase of hepatitis B. Of the 29 IgM anti-HBc positive specimens, 28 were found to be HBeAg positive, 18 of these patients were hemodialysed. 62 among 63 HBsAg positive blood donors had IgG anti-HBc, 6 associated with HBeAg and 56 with anti-HBe. All anti-HBc of anti-HBs positive sera were of IgG class (patients or blood donors). In order to estimate the anti-HBc titer, we have determined the per cent inhibition of 134 HBsAg and 46 anti-HBs positive sera diluted to 1 : 100. We correlate the presence of HBsAg --regardless of the level of titer of it --with high titers of anti-HBc and the presence of anti-HBs with low titers (P less than less than 0,0001). These results are very instructive with regard to the problem of anti-HBc titer and possibility of persisting HBV and we support the hypothesis that HBsAg negative but strongly anti-HBc positive blood might be infectious. IgM anti-HBc are on the average of lower titer than IgG anti-HBc, but we did not observe difference in IgG anti-HBc titer between HBeAg positive sera and anti-HBe, HBsAg positive sera.
本文描述了一种检测IgM类抗-HBc的方法。在用对蛋白A呈阳性的金黄色葡萄球菌细胞优先吸收IgG抗-HBc抗体后,我们通过放射免疫测定法检测了上清液(吸收后的血清)中残留的IgM抗-HBc。在3例持续性感染患者中研究抗-HBc的出现情况和时间进程,结果显示在急性肝炎病例中,IgM抗-HBc持续约2个月。IgM抗-HBc(近期HBV感染的标志物)被发现是诊断隐匿性肝炎伴短暂或不可检测的HBs抗原血症(病例5)的有用工具。通过放射免疫测定法测定了68例HBsAg阳性患者中IgM或IgG抗-HBc、HBeAg和抗-HBe的存在情况。抗-HBc的免疫球蛋白类别(IgM或IgG)取决于乙型肝炎的阶段。在29份IgM抗-HBc阳性标本中,发现28份HBeAg阳性,其中18例患者接受了血液透析。63例HBsAg阳性献血者中有62例有IgG抗-HBc,6例与HBeAg相关,56例与抗-HBe相关。抗-HBs阳性血清中的所有抗-HBc均为IgG类(患者或献血者)。为了估计抗-HBc滴度,我们测定了134份HBsAg阳性血清和46份抗-HBs阳性血清稀释至1:100后的抑制百分比。我们将HBsAg的存在(无论其滴度水平如何)与高滴度抗-HBc相关联,将抗-HBs的存在与低滴度相关联(P远小于0.0001)。这些结果对于抗-HBc滴度问题以及HBV持续存在的可能性具有重要指导意义,并且我们支持这样的假设,即HBsAg阴性但抗-HBc强阳性的血液可能具有传染性。IgM抗-HBc的平均滴度低于IgG抗-HBc,但我们未观察到HBeAg阳性血清与抗-HBe、HBsAg阳性血清之间IgG抗-HBc滴度的差异。